Hengyu Medical Secures Tens of Millions in Funding and Files IPO Prospectus

36Kr learned that "Horimed" announced the completion of tens of millions of yuan in financing. This round was led by existing shareholder Tasly Capital Holding (Beijing) Co., Ltd., with participation from the biopharmaceutical fund jointly established by Haihe Fund and HAITAI Capital, and HAOYUE CAPITAL continued to serve as the exclusive financial advisor. This round of financing will support R&D, production, and registration, with a focus on accelerating the commercial promotion of products already on the market.